Drug profile · INN
coronavirus (sars-cov-2) rna vaccine (active ingredients: elasomeran and davesomeran)
SPIKEVAX (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.4-5) PARTIAL CHANGE APPROVAL
- Patents linked
- 0
- News articles
- 0
Quick answer
coronavirus (sars-cov-2) rna vaccine (active ingredients: elasomeran and davesomeran) (SPIKEVAX (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.4-5) PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.
Key facts
Frequently asked questions
What is coronavirus (sars-cov-2) rna vaccine (active ingredients: elasomeran and davesomeran)?
coronavirus (sars-cov-2) rna vaccine (active ingredients: elasomeran and davesomeran) (SPIKEVAX (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.4-5) PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for coronavirus (sars-cov-2) rna vaccine (active ingredients: elasomeran and davesomeran)?
SPIKEVAX (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.4-5) PARTIAL CHANGE APPROVAL is a marketed brand name for coronavirus (sars-cov-2) rna vaccine (active ingredients: elasomeran and davesomeran). Check FDA Drugs@FDA for the current US label holder and prescribing information.